BML Investment Partners, L.P. - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Aclaris Therapeutics, Inc. (ACRS)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: BML Investment Partners, L.P.
Security: Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value
Symbol: ACRS
Shares outstanding: 107M shares
Disclosed Ownership: 14.3M shares
Ownership: 13.3%
Form type: SCHEDULE 13G/A
Date filed: 2/13/2025, 02:26 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	13.3%	14.3M	0	14.3M	Braden M Leonard	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member